Correlation Between IShares Genomics and First Trust
Can any of the company-specific risk be diversified away by investing in both IShares Genomics and First Trust at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Genomics and First Trust into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Genomics Immunology and First Trust NASDAQ, you can compare the effects of market volatilities on IShares Genomics and First Trust and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Genomics with a short position of First Trust. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Genomics and First Trust.
Diversification Opportunities for IShares Genomics and First Trust
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between IShares and First is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding iShares Genomics Immunology and First Trust NASDAQ in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on First Trust NASDAQ and IShares Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Genomics Immunology are associated (or correlated) with First Trust. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of First Trust NASDAQ has no effect on the direction of IShares Genomics i.e., IShares Genomics and First Trust go up and down completely randomly.
Pair Corralation between IShares Genomics and First Trust
Given the investment horizon of 90 days IShares Genomics is expected to generate 2.78 times less return on investment than First Trust. But when comparing it to its historical volatility, iShares Genomics Immunology is 1.16 times less risky than First Trust. It trades about 0.08 of its potential returns per unit of risk. First Trust NASDAQ is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 3,315 in First Trust NASDAQ on September 1, 2024 and sell it today you would earn a total of 242.00 from holding First Trust NASDAQ or generate 7.3% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
iShares Genomics Immunology vs. First Trust NASDAQ
Performance |
| Timeline |
| iShares Genomics Imm |
| First Trust NASDAQ |
IShares Genomics and First Trust Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with IShares Genomics and First Trust
The main advantage of trading using opposite IShares Genomics and First Trust positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Genomics position performs unexpectedly, First Trust can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in First Trust will offset losses from the drop in First Trust's long position.| IShares Genomics vs. Fidelity MSCI Financials | IShares Genomics vs. Fidelity MSCI Consumer | IShares Genomics vs. Fidelity MSCI Consumer | IShares Genomics vs. Fidelity MSCI Industrials |
| First Trust vs. SPDR Kensho New | First Trust vs. Global X FinTech | First Trust vs. Invesco SP SmallCap | First Trust vs. iShares Genomics Immunology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |